Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.
MGH Research Fellow Bryan Lenneman, PhD, is interested in utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.
Rachel Ende, PhD, Postdoctoral Scholar in the lab of CIMAR’s Dr. Joan Mecsas, studying mechanisms of synergistic antibiotic interactions against Klebsiella pneumoniae in the lungs
Postdoctoral Scholar & first-year IRACDA Fellow in the lab of Levy CIMAR’s Dr. Joan Mecsas, studying mechanisms of synergistic antibiotic interactions against Klebsiella pneumoniae in the lungs
